Homeostasis, injury and recovery dynamics at multiple scales in a self-organizing mouse intestinal crypt

  1. Louis Gall
  2. Carrie Duckworth
  3. Ferran Jardi
  4. Lieve Lammens
  5. Aimee Parker
  6. Ambra Bianco
  7. Holly Kimko
  8. David Mark Pritchard
  9. Carmen Pin  Is a corresponding author
  1. AstraZeneca, United Kingdom
  2. University of Liverpool, United Kingdom
  3. Janssen, Belgium
  4. Quadram Institute, United Kingdom

Abstract

The maintenance of the functional integrity of the intestinal epithelium requires a tight coordination between cell production, migration and shedding along the crypt-villus axis. Dysregulation of these processes may result in loss of the intestinal barrier and disease. With the aim of generating a more complete and integrated understanding of how the epithelium maintains homeostasis and recovers after injury, we have built a multi-scale agent-based model (ABM) of the mouse intestinal epithelium. We demonstrate that stable, self-organizing behaviour in the crypt emerges from the dynamic interaction of multiple signalling pathways, such as Wnt, Notch, BMP, ZNRF3/RNF43 and YAP-Hippo pathways, which regulate proliferation and differentiation, respond to environmental mechanical cues, form feedback mechanisms and modulate the dynamics of the cell cycle protein network. The model recapitulates the crypt phenotype reported after persistent stem cell ablation and after the inhibition of the CDK1 cycle protein. Moreover, we simulated 5-fluorouracil (5-FU)-induced toxicity at multiple scales starting from DNA and RNA damage, which disrupts the cell cycle, cell signalling, proliferation, differentiation and migration and leads to loss of barrier integrity. During recovery, our in-silico crypt regenerates its structure in a self-organizing, dynamic fashion driven by dedifferentiation and enhanced by negative feedback loops. Thus, the model enables the simulation of xenobiotic-, in particular chemotherapy-, induced mechanisms of intestinal toxicity and epithelial recovery. Overall, we present a systems model able to simulate the disruption of molecular events and its impact across multiple levels of epithelial organization and demonstrate its application to epithelial research and drug development.

Data availability

The current manuscript is a computational study. No data have been generated for this manuscript. Modelling code is uploaded as Source Code.zip file

Article and author information

Author details

  1. Louis Gall

    Clinical and Quantitative Pharmacology, AstraZeneca, Cambridge, United Kingdom
    Competing interests
    Louis Gall, Employee and shareholder of AstraZeneca Plc.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1805-2357
  2. Carrie Duckworth

    Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom
    Competing interests
    No competing interests declared.
  3. Ferran Jardi

    Preclinical Sciences and Translational Safety, Janssen, Beerse, Belgium
    Competing interests
    Ferran Jardi, Employee of Johnson & Johnson..
  4. Lieve Lammens

    Preclinical Sciences and Translational Safety, Janssen, Beerse, Belgium
    Competing interests
    Lieve Lammens, Employee and shareholder of Johnson & Johnson..
  5. Aimee Parker

    Gut Microbes and Health Programme, Quadram Institute, Norwich, United Kingdom
    Competing interests
    No competing interests declared.
  6. Ambra Bianco

    Clinical Pharmacology and Safety Sciences, AstraZeneca, Cambridge, United Kingdom
    Competing interests
    Ambra Bianco, Employee and shareholder of AstraZeneca Plc.
  7. Holly Kimko

    Clinical and Quantitative Pharmacology, AstraZeneca, Cambridge, United Kingdom
    Competing interests
    Holly Kimko, Employee and shareholder of AstraZeneca Plc.
  8. David Mark Pritchard

    Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7971-3561
  9. Carmen Pin

    Clinical and Quantitative Pharmacology, AstraZeneca, Cambridge, United Kingdom
    For correspondence
    carmen.pin@astrazeneca.com
    Competing interests
    Carmen Pin, Employee and shareholder of AstraZeneca Plc.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8734-6167

Funding

European Federation of Pharmaceutical Industries and Associations (Innovative Medicines Initiative 2,No. 116030)

  • Louis Gall
  • Carrie Duckworth
  • Ferran Jardi
  • Lieve Lammens
  • David Mark Pritchard
  • Carmen Pin

Horizon 2020 Framework Programme (Innovative Medicines Initiative 2,No. 116030)

  • Louis Gall
  • Carrie Duckworth
  • Ferran Jardi
  • Lieve Lammens
  • David Mark Pritchard
  • Carmen Pin

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All experiments were performed in an Association for Assessment and Accreditation of Laboratory Animal Care approved rodent facility and in accordance with the applicable animal welfare guidelines and legislation. Experimental procedures were approved by the institutional ethics committee. Ten-week-old male C57/BL6Y mice were obtained from Charles River (France). Mice were housed in polysulfon cages with corncob bedding under standard conditions of room temperature (21{degree sign}C {plus minus} 2), relative humidity (55% {plus minus} 15) and a 12-h light cycle. Water and a certified rodent pelleted maintenance diet were supplied ad libitum. Nest material and rodent retreats were provided for environmental enrichment.

Copyright

© 2023, Gall et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,301
    views
  • 201
    downloads
  • 1
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Louis Gall
  2. Carrie Duckworth
  3. Ferran Jardi
  4. Lieve Lammens
  5. Aimee Parker
  6. Ambra Bianco
  7. Holly Kimko
  8. David Mark Pritchard
  9. Carmen Pin
(2023)
Homeostasis, injury and recovery dynamics at multiple scales in a self-organizing mouse intestinal crypt
eLife 12:e85478.
https://doi.org/10.7554/eLife.85478

Share this article

https://doi.org/10.7554/eLife.85478

Further reading

    1. Biochemistry and Chemical Biology
    2. Computational and Systems Biology
    Shinichi Kawaguchi, Xin Xu ... Toshie Kai
    Research Article

    Protein–protein interactions are fundamental to understanding the molecular functions and regulation of proteins. Despite the availability of extensive databases, many interactions remain uncharacterized due to the labor-intensive nature of experimental validation. In this study, we utilized the AlphaFold2 program to predict interactions among proteins localized in the nuage, a germline-specific non-membrane organelle essential for piRNA biogenesis in Drosophila. We screened 20 nuage proteins for 1:1 interactions and predicted dimer structures. Among these, five represented novel interaction candidates. Three pairs, including Spn-E_Squ, were verified by co-immunoprecipitation. Disruption of the salt bridges at the Spn-E_Squ interface confirmed their functional importance, underscoring the predictive model’s accuracy. We extended our analysis to include interactions between three representative nuage components—Vas, Squ, and Tej—and approximately 430 oogenesis-related proteins. Co-immunoprecipitation verified interactions for three pairs: Mei-W68_Squ, CSN3_Squ, and Pka-C1_Tej. Furthermore, we screened the majority of Drosophila proteins (~12,000) for potential interaction with the Piwi protein, a central player in the piRNA pathway, identifying 164 pairs as potential binding partners. This in silico approach not only efficiently identifies potential interaction partners but also significantly bridges the gap by facilitating the integration of bioinformatics and experimental biology.

    1. Computational and Systems Biology
    2. Neuroscience
    Brian DePasquale, Carlos D Brody, Jonathan W Pillow
    Research Article Updated

    Accumulating evidence to make decisions is a core cognitive function. Previous studies have tended to estimate accumulation using either neural or behavioral data alone. Here, we develop a unified framework for modeling stimulus-driven behavior and multi-neuron activity simultaneously. We applied our method to choices and neural recordings from three rat brain regions—the posterior parietal cortex (PPC), the frontal orienting fields (FOF), and the anterior-dorsal striatum (ADS)—while subjects performed a pulse-based accumulation task. Each region was best described by a distinct accumulation model, which all differed from the model that best described the animal’s choices. FOF activity was consistent with an accumulator where early evidence was favored while the ADS reflected near perfect accumulation. Neural responses within an accumulation framework unveiled a distinct association between each brain region and choice. Choices were better predicted from all regions using a comprehensive, accumulation-based framework and different brain regions were found to differentially reflect choice-related accumulation signals: FOF and ADS both reflected choice but ADS showed more instances of decision vacillation. Previous studies relating neural data to behaviorally inferred accumulation dynamics have implicitly assumed that individual brain regions reflect the whole-animal level accumulator. Our results suggest that different brain regions represent accumulated evidence in dramatically different ways and that accumulation at the whole-animal level may be constructed from a variety of neural-level accumulators.